These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 22891358

  • 1. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.
    Kim YK, Lee WJ, Park MJ, Kim SH, Rhim H, Choi D.
    Radiology; 2012 Oct; 265(1):104-14. PubMed ID: 22891358
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J, Kim YK, Jeong WK, Choi D, Rhim H, Lee WJ.
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM, Kim SH, Kim YK, Choi D.
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [Abstract] [Full Text] [Related]

  • 6. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T.
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Non-hypervascular hypointense nodules ≥1 cm on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging in cirrhotic livers.
    Yoon JH, Lee JM, Yang HK, Lee KB, Jang JJ, Han JK, Choi BI.
    Dig Dis; 2014 Jul; 32(6):678-89. PubMed ID: 25376284
    [Abstract] [Full Text] [Related]

  • 9. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ, Kim YK, Lee MH, Lee JH.
    Acta Radiol; 2013 Mar 01; 54(2):127-36. PubMed ID: 23148300
    [Abstract] [Full Text] [Related]

  • 10. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
    Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, Choi BI.
    Radiology; 2013 Jun 01; 267(3):776-86. PubMed ID: 23401584
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.
    Briani C, Di Pietropaolo M, Marignani M, Carbonetti F, Begini P, David V, Iannicelli E.
    J Gastrointest Cancer; 2018 Sep 01; 49(3):302-310. PubMed ID: 28547117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
    Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY.
    Radiology; 2010 May 01; 255(2):459-66. PubMed ID: 20413759
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.
    Radiology; 2012 Sep 01; 264(3):761-70. PubMed ID: 22843769
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.